Contained Annulus Rupture after TAVR: What Should We Do?

Courtesy of Dr. Carlos Fava.

Aortic annulus rupture is a catastrophic event that presents in nearly 0.9% of cases, but there is another entity called contained annulus rupture, associated to oversized devices and annulus calcification and diagnosed with CT angiography, with up to 5% frequency.

tavi calcificación del anillo mitral

1602 patients from the ENCORE registry were analyzed. 21 of these patients presented contained annulus rupture (1.3%). 

Mean age was 81.9 years, 18 were women and most of them received self-expandable valves.

In 17 cases, contained annulus rupture was diagnosed with CT angiography, in 2 with transesophageal echocardiography (TEE), and in the remaining 2 with post TAVR CT angiography, due to clinical suspicion. 

Follow up was at 2.3 years. No patient presented symptoms or required reintervention and 9 died of non-cardiac cause. 


Read also: The FDA Approves Ticagrelor for Primary Prevention in High Risk Patients.


After angio CT at follow-up, one presented regression, 7 remained stable and 3 presented remission. 

Conclusion

Outcomes of this international multicenter registry show that contained annulus rupture had a favorable evolution, with supports the strategy of “watch and wait” used with these patients. 

Courtesy of Dr. Carlos Fava.

Original Title: Long-term follow-up of patients with contained annulus ruptures after TAVI: the EuropeaN COntained RupturE (ENCORE) Registry.

Reference: Philipp Breitbart,et al. EuroIntervention 2020;16:83-8.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...